Literature DB >> 7507012

MHC class I, MHC class II and intercellular adhesion molecule-1 (ICAM-1) expression in inflammatory myopathies.

E Bartoccioni1, S Gallucci, F Scuderi, E Ricci, S Servidei, A Broccolini, P Tonali.   

Abstract

We investigated the relationship between the MHC-I, MHC-II and intercellular adhesion molecule-1 (ICAM-1) expression on myofibres and the presence of inflammatory cells in muscle specimens of 18 patients with inflammatory myopathies (nine polymyositis, seven dermatomyositis, two inclusion body myositis). We observed MHC-I expression in muscle fibres, infiltrating mononuclear cells and endothelial cells in every specimen. In seven patients, some muscle fibres were MHC-II-positive for the DR antigen, while the DP and DQ antigens were absent. ICAM-1 expression, detected in seven patients, was found in clusters of myofibres, associated with a marked MHC-I positivity and a widespread mononuclear infiltration. Most of the ICAM-1-positive fibres were regenerating fibres. Furthermore, some fibres expressed both ICAM-1 and DR antigens near infiltrating cells. This finding could support the hypothesis that myofibres may themselves be the site of autosensitization.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7507012      PMCID: PMC1534629          DOI: 10.1111/j.1365-2249.1994.tb06032.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  30 in total

1.  Localization of interferons and interleukin 2 in polymyositis and muscular dystrophy.

Authors:  D A Isenberg; D Rowe; M Shearer; D Novick; P C Beverley
Journal:  Clin Exp Immunol       Date:  1986-02       Impact factor: 4.330

2.  Lymphocyte antigen Leu-19 as a molecular marker of regeneration in human skeletal muscle.

Authors:  W Schubert; K Zimmermann; M Cramer; A Starzinski-Powitz
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

3.  Cotransfection of ICAM-1 and HLA-DR reconstitutes human antigen-presenting cell function in mouse L cells.

Authors:  D M Altmann; N Hogg; J Trowsdale; D Wilkinson
Journal:  Nature       Date:  1989-04-06       Impact factor: 49.962

4.  Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1).

Authors:  M L Dustin; R Rothlein; A K Bhan; C A Dinarello; T A Springer
Journal:  J Immunol       Date:  1986-07-01       Impact factor: 5.422

5.  Monoclonal antibody analysis of mononuclear cells in myopathies. V: Identification and quantitation of T8+ cytotoxic and T8+ suppressor cells.

Authors:  K Arahata; A G Engel
Journal:  Ann Neurol       Date:  1988-05       Impact factor: 10.422

6.  Major histocompatibility complex class I antigen expression, immunolocalization of interferon subtypes, and T cell-mediated cytotoxicity in myopathies.

Authors:  A M Emslie-Smith; K Arahata; A G Engel
Journal:  Hum Pathol       Date:  1989-03       Impact factor: 3.466

7.  Expression of immunoreactive major histocompatibility complex products in human skeletal muscles.

Authors:  G Karpati; Y Pouliot; S Carpenter
Journal:  Ann Neurol       Date:  1988-01       Impact factor: 10.422

8.  Expression of class I and class II MHC antigens in neuromuscular diseases.

Authors:  R M McDouall; M J Dunn; V Dubowitz
Journal:  J Neurol Sci       Date:  1989-02       Impact factor: 3.181

9.  Increased expression of HLA ABC class I antigens by muscle fibres in Duchenne muscular dystrophy, inflammatory myopathy, and other neuromuscular disorders.

Authors:  S T Appleyard; M J Dunn; V Dubowitz; M L Rose
Journal:  Lancet       Date:  1985-02-16       Impact factor: 79.321

10.  Functional evidence that intercellular adhesion molecule-1 (ICAM-1) is a ligand for LFA-1-dependent adhesion in T cell-mediated cytotoxicity.

Authors:  M W Makgoba; M E Sanders; G E Ginther Luce; E A Gugel; M L Dustin; T A Springer; S Shaw
Journal:  Eur J Immunol       Date:  1988-04       Impact factor: 5.532

View more
  23 in total

1.  Expression of intercellular adhesion molecule-1 by myofibers in mdx mice.

Authors:  Maria J Torres-Palsa; Matthew V Koziol; Qingnian Goh; Peter A Cicinelli; Jennifer M Peterson; Francis X Pizza
Journal:  Muscle Nerve       Date:  2015-06-03       Impact factor: 3.217

2.  Limited effects of high-dose intravenous immunoglobulin (IVIG) treatment on molecular expression in muscle tissue of patients with inflammatory myopathies.

Authors:  Sevim Barbasso Helmers; Maryam Dastmalchi; Helene Alexanderson; Inger Nennesmo; Mona Esbjörnsson; Björn Lindvall; Ingrid E Lundberg
Journal:  Ann Rheum Dis       Date:  2007-02-02       Impact factor: 19.103

3.  Signs of inflammation in both symptomatic and asymptomatic muscles from patients with polymyositis and dermatomyositis.

Authors:  C Dorph; P Englund; I Nennesmo; I E Lundberg
Journal:  Ann Rheum Dis       Date:  2006-07-10       Impact factor: 19.103

4.  Expression of the costimulatory molecule BB-1, the ligands CTLA-4 and CD28, and their mRNA in inflammatory myopathies.

Authors:  K Murata; M C Dalakas
Journal:  Am J Pathol       Date:  1999-08       Impact factor: 4.307

5.  A variety of cytokines and immunologically relevant surface molecules are expressed by normal human skeletal muscle cells under proinflammatory stimuli.

Authors:  K Nagaraju; N Raben; G Merritt; L Loeffler; K Kirk; P Plotz
Journal:  Clin Exp Immunol       Date:  1998-09       Impact factor: 4.330

Review 6.  The role of cytokines, chemokines, and adhesion molecules in the pathogenesis of idiopathic inflammatory myopathies.

Authors:  I E Lundberg
Journal:  Curr Rheumatol Rep       Date:  2000-06       Impact factor: 4.592

7.  Myofiber stress-response in myositis: parallel investigations on patients and experimental animal models of muscle regeneration and systemic inflammation.

Authors:  Maurizio Vitadello; Andrea Doria; Elena Tarricone; Anna Ghirardello; Luisa Gorza
Journal:  Arthritis Res Ther       Date:  2010-03-24       Impact factor: 5.156

8.  Upregulation of MHC class I in transgenic mice results in reduced force-generating capacity in slow-twitch muscle.

Authors:  Stina Salomonsson; Cecilia Grundtman; Shi-Jin Zhang; Johanna T Lanner; Charles Li; Abram Katz; Lucy R Wedderburn; Kanneboyina Nagaraju; Ingrid E Lundberg; Håkan Westerblad
Journal:  Muscle Nerve       Date:  2009-05       Impact factor: 3.217

Review 9.  Advances in the immunopathophysiology of the idiopathic inflammatory myopathies: not as simple as suspected.

Authors:  Gerald J D Hengstman
Journal:  Curr Rheumatol Rep       Date:  2007-08       Impact factor: 4.592

Review 10.  Cytokine response in inflammatory myopathies.

Authors:  Anne Tournadre; Pierre Miossec
Journal:  Curr Rheumatol Rep       Date:  2007-08       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.